Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial

What is the purpose of this trial?

The investigators hypothesize that treatment with the iron chelator, Deferoxamine Mesylate, improves the outcome of patients with brain hemorrhage.

The purpose of this study is to determine whether treatment with Deferoxamine Mesylate is of sufficient promise to improve outcome before pursuing a larger clinical trial to examine its effectiveness as a treatment for intracerebral hemorrhage.


Participation Guidelines

Ages: 18 - 80 years

Gender: Both


Beth Israel Deaconess Medical Center

Dates: 08/27/2014 - 02/28/2017

Last Updated: 10/13/2015

Study HIC#: 1301011333

Get Involved

For more information about this study, contact:
Sara Jasak
203-737-7629
sara.jasak@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image